Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nootkatone is a naturally occurring sesquiterpene ketone found primarily in grapefruit and Alaskan yellow cedar. It is the key aroma compound responsible for the characteristic scent and flavor of grapefruit. Commercially produced from valencene via chemical or biotechnological oxidation processes[3][10], it is used as a flavoring agent in foods and beverages as well as a fragrance ingredient in cosmetics and perfumery[2][8]. Nootkatone has been approved by the US EPA as an active ingredient for use in insecticides and skin-applied repellents due to its effectiveness against ticks (including deer ticks), mosquitoes (including those that transmit Zika virus), bed bugs and other arthropods[1][3][7]. Its mechanism of action involves activation of α‑adrenergic type 1 octopamine receptors in susceptible arthropods leading to fatal spasms[3]. In mammals it shows low toxicity with minimal irritation potential[7], is non-sensitizing to skin or eyes at typical exposure levels[7], and is considered safe for use as a food additive. Preclinical studies suggest additional biological activities including anti-inflammatory effects via AMPK activation in skeletal muscle/liver cells; antiallergic/antiplatelet activity; possible benefits on metabolic-associated fatty liver disease through regulation of glycolipid metabolism by activating AMPK and inhibiting MAPK signaling pathways; anti-obesity effects; improved physical performance; protection against chronic kidney injury; anti-anxiety/antidepressant-like effects—all primarily demonstrated in animal models or cell culture systems rather than clinical trials[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nootkatone.